Papers to Appear in Forthcoming Issues

(Received and Accepted Dates Follow Title) ating Levels of IL-10 Are Critically Related to Growth and Rejection Patterns of Murine Mastocytoma Cells. Ursula Grohmann, Silvia Silla, Maria L. Belladonna, Roberta Bianchi, Ciriana Orabona, Paolo Puccetti, and Maria C. Fioretti. (Received 1/13/97; accepted 8/5/97.) ive Antigen Presenting Activity of Cortical Thymic Epithelial Cells against CD4+T Cells Associated with both Lack of Costimulatory Molecules and Inefficient Presentation of MHC–Peptide Ligands. Rika Kaneda, Kazuya Iwabuchi, Michiyuki Kasai, Masaaki Murakami, Toshimitu Uede, and Kazunori Onoé.(Received 3/26/97; accepted 8/5/97.) ged Allogeneic and Xenogeneic Microchimerism in Unmatched Primates without Immunosuppression by Intrathymic Implantation of CD34+Donor Marrow Cells. Margaret D. Allen, John Weyhrich, Lakshmi Gaur, Hiroji Akimoto, Jeffrey Hall, Joy Dalesandro, Sadahiro Sai, Robert Thomas, Karen A. Nelson, and Robert G. Andrews.(Received 3/18/97; accepted 8/12/97.) tion of the CD2 Receptor and Not Disruption of the CD2/CD48 Interaction Is the Principal Action of CD2-Mediated Immunosuppression in the Rat. Bernd Sido, Gerd Otto, Rainer Zimmermann, Petra Müller, Stefan C. Meuer, and Thomas J. Dengler. (Received 1/14/97; accepted 9/3/97.) isms of Antigen Receptor-Dependent Apoptosis of Human B Lymphoma Cells Probed with a Panel of Twenty-Seven Monoclonal Antibodies. Gillian Grafton, Margaret Goodall, Christopher D. Gregory, and John Gordon. (Received 12/10/96; accepted 9/3/97.) nd IL-7 Induce Heterodimerization of STAT5 Isoforms in Human Peripheral Blood T Lymphoblasts. Louis A. Rosenthal, Karen D. Winestock, and David S. Finbloom. (Received 4/14/97; accepted 9/10/97.) le of CD40–CD40 Ligand Interactions in Suppression of Human B Cell Responsiveness by CD4+T Cells. Shunsei Hirohata.(Received 4/24/97; accepted 9/10/97.)